The current TBIO market cap is 5.73M. The company's latest EPS is USD -27.6512 and P/E is -0.12.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 8.65M | 5.56M | 6.98M | 3.44M | 299k |
Operating Income | -7.97M | -10.12M | -17.48M | -8.52M | -10.76M |
Net Income | -8.44M | -11.2M | -18.27M | -9.22M | -13.18M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 4.81M | 6.58M | 11.04M | 27.44M | 27.51M |
Operating Income | -6.98M | -16.36M | -35.37M | -46.49M | -46.54M |
Net Income | -8.3M | -18.01M | -38.96M | -48.47M | -49.02M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 114.53M | 105.03M | 70.41M | 63.33M | 52.73M |
Total Liabilities | 58.46M | 58.54M | 40.87M | 41.68M | 42.78M |
Total Equity | 27.92M | 17.77M | 238k | -8.24M | -20.54M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 38.76M | 26.86M | 116.26M | 81.36M | 70.41M |
Total Liabilities | 7.35M | 13.41M | 25.47M | 34.8M | 40.87M |
Total Equity | -7.5M | -25.46M | 90.78M | 46.57M | 238k |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -21.47M | -27.36M | -34.67M | -3.24M | -8.58M |
Investing | 10.97M | -12.24M | -5.74M | 12.25M | 13.38M |
Financing | 26.69M | 26.59M | 11.57M | -27k | -34k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.39M | -15.38M | -36.7M | -38.72M | -34.67M |
Investing | -79k | -204k | -15.04M | -18.01M | -5.74M |
Financing | 35.11M | -96k | 121.08M | 4.51M | 11.57M |
Market Cap | 5.73M |
Price to Earnings Ratio | -0.12 |
Price to Sales Ratio | 0.21 |
Price to Cash Ratio | 3.65 |
Price to Book Ratio | 0.19 |
Dividend Yield | - |
Shares Outstanding | 1.77M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 4.39M |
52 Week Change | -81.69% |
52 Week High | 19.62 |
52 Week Low | 1.27 |
Spread (Intraday) | 0.2 (5.97%) |
Company Name | Telesis Bio Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.codexdna.com |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.